Kyung Dong Pharmaceutical Co (XKRX:011040) Construction In Progress : ₩5,378 Mil (As of Mar. 2024)

View and export this data going back to 1992. Start your Free Trial

What is Kyung Dong Pharmaceutical Co Construction In Progress?

Kyung Dong Pharmaceutical Co's quarterly construction in progress increased from Sep. 2023 (₩2,897 Mil) to Dec. 2023 (₩4,438 Mil) and increased from Dec. 2023 (₩4,438 Mil) to Mar. 2024 (₩5,378 Mil).

Kyung Dong Pharmaceutical Co's annual construction in progress declined from Dec. 2021 (₩21,513 Mil) to Dec. 2022 (₩2,565 Mil) but then increased from Dec. 2022 (₩2,565 Mil) to Dec. 2023 (₩4,438 Mil).

Kyung Dong Pharmaceutical Co Construction In Progress Historical Data

The historical data trend for Kyung Dong Pharmaceutical Co's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kyung Dong Pharmaceutical Co Construction In Progress Chart

Kyung Dong Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Construction In Progress

Get a 7-Day Free Trial

1,457.57

21,472.90

21,513.10

2,565.13

4,437.87

Kyung Dong Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Construction In Progress	Get a 7-Day Free Trial															2,355.63	1,652.23	2,897.21	4,437.87	5,378.38

Kyung Dong Pharmaceutical Co Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

Kyung Dong Pharmaceutical Co (XKRX:011040) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kyung Dong Pharmaceutical Co Ltd (XKRX:011040) » Definitions » Construction In Progress

Traded in Other Exchanges

N/A

Address

1926, Nambusunhwan-ro, Gwanak-gu, Seoul, KOR

Website

http://www.kdpharma.co.kr

Kyung Dong Pharmaceutical Co Ltd is a South Korea-based company engaged in the manufacturing and marketing of pharmaceutical products. Its products include liver therapies, gastrointestinal drugs, antimigraine drugs, antiviral, anti-obesity medications, antibacterial drugs, antidiabetic drugs, antifungal, vitamins, as well as drugs for osteoporosis, cardiovascular, muscle relaxant, neuropathic and other diseases.

Kyung Dong Pharmaceutical Co (XKRX:011040) Headlines

No Headlines